U002 What's New in Onychomycosis?
DESCRIPTION
The epidemiology of onychomycosis is changing with an increase in the number of non-dermatophyte molds and mixed infections: an update will be presented. The newer methods of diagnosing onychomycosis will be compared and contrasted with the traditional methods. The expanding repertoire of newer orals, topicals and devices for onychomycosis will be discussed. The emergence of resistant organisms and management options will be highlighted. Strategies for sanitizing shoes and socks will be presented, along with prophylactic treatments to reduce recurrence. The session will be interactive with periodic questions to the audience and audience participation will be encouraged.
LEARNING OBJECTIVES
Describe the pros and cons of the traditional and newer methods for diagnosing onychomycosis
Discuss why some patients demonstrate sub-optimal response to treatment and how to increase efficacy
Choose optimal treatment of non-dermatophyte molds and mixed infection onychomycosis
SCHEDULE
7:30 AM
Introduction/What's New in the Epidemiology of Onychomycosis?
Aditya K. Gupta, MD, PhD, FAAD
7:37 AM
What's New in the Diagnosis of Onychomycosis?
Molly A. Hinshaw, MD, FAAD
7:44 AM
What's New in Pediatric Onychomycosis?
Julie Mervak, MD, FAAD
7:51 AM
What's New in Treatment of Non-Dermatophyte Mould Onychomycosis?
Bianca Maria Piraccini, MD, IFAAD
8:01 AM
What's New in Topical Treatments and Devices for Treating Onychomycosis?
Shari Lipner, MD, PhD, FAAD
8:11 AM
What's New in Oral Therapy/Resistance in Onychomycosis?
Aditya K. Gupta, MD, PhD, FAAD
8:21 AM
Questions and Answers
DIRECTOR
Aditya K. Gupta, MD, PhD, FAAD
SPEAKERS
Molly A. Hinshaw, MD, FAAD
Shari Lipner, MD, PhD, FAAD
Julie Mervak, MD, FAAD
Bianca Maria Piraccini, MD, IFAAD
HANDOUTS
DISCLOSURES
Aditya K. Gupta, MD, PhD, FAAD
Bausch Health – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Fees); Emblation Limited – Investigator(Grants/Research Funding); Moberg Derma – Consultant(Fees); Ortho Dermatologics – Consultant(Fees);
Molly A. Hinshaw, MD, FAAD
BiaCure Therapies Inc – Founder(Stock);
Shari Lipner, MD, PhD, FAAD
BelleTorus Corporation – Investigator(Grants/Research Funding); Moberg Pharma North America LLC – Investigator(Grants/Research Funding);
Julie Mervak, MD, FAAD
No financial relationships exist with ineligible companies.
Bianca Maria Piraccini, MD, IFAAD
ISDIN – Consultant(Fees); L'Oréal France – Advisory Board(Fees); Pierre Fabre Dermo Cosmetique France – Advisory Board(Fees);